CPA
SVNT

Cowen Prime Advisors’s SAVIENT PHARMACEUTICALS INC SVNT Stock Holding History

Cowen Prime Advisors’s Portfolio SVNT Stock Details SVNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-5,450
Closed -$3K – 304
2013
Q3 		$3K Buy
+5,450
New +$3.49K ﹤0.01% 256

Other funds holding SVNT

Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
FHC
First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return
PSC
Prentiss Smith & Co Brattleboro, Vermont $172M AUM 21.18% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Cowen Prime Advisors's SVNT Position: Q4 2013 in Review

Cowen Prime Advisors sold out of SAVIENT PHARMACEUTICALS INC (SVNT) in Q4 2013, closing a stake of 5,450 shares — an estimated $3K sold.

Cowen Prime Advisors first reported a position in SVNT in Q3 2013 and held it in 1 quarter. The position peaked at $3K in Q3 2013. 7 funds tracked by Wall St. Rank hold SVNT as of Q4 2013.

  • Cowen Prime Advisors reported no remaining SAVIENT PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Cowen Prime Advisors sold 5,450 SAVIENT PHARMACEUTICALS INC shares in Q4 2013, an estimated $3K.
  • Cowen Prime Advisors first reported a position in SAVIENT PHARMACEUTICALS INC in Q3 2013 and held it in 1 quarter.
  • Cowen Prime Advisors's SAVIENT PHARMACEUTICALS INC position peaked at $3K in Q3 2013.
  • 7 funds tracked by Wall St. Rank held SAVIENT PHARMACEUTICALS INC as of Q4 2013.

Based on Cowen Prime Advisors's 13F filing for Q4 2013, filed 13 Feb 2014.